These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 16286177

  • 1. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
    Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, Kim SG, Martin LW, Rosenberg Y, Wyse DG, AFFIRM Investigators.
    J Am Coll Cardiol; 2005 Nov 15; 46(10):1891-9. PubMed ID: 16286177
    [Abstract] [Full Text] [Related]

  • 2. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Jenkins LS, Brodsky M, Schron E, Chung M, Rocco T, Lader E, Constantine M, Sheppard R, Holmes D, Mateski D, Floden L, Prasun M, Greene HL, Shemanski L.
    Am Heart J; 2005 Jan 15; 149(1):112-20. PubMed ID: 15660042
    [Abstract] [Full Text] [Related]

  • 3. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).
    Freudenberger RS, Wilson AC, Kostis JB, AFFIRM Investigators and Committees.
    Am J Cardiol; 2007 Jul 15; 100(2):247-52. PubMed ID: 17631079
    [Abstract] [Full Text] [Related]

  • 4. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
    Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL, National Heart, Lung, and Blood Institute AFFIRM Investigators.
    Arch Intern Med; 2005 May 23; 165(10):1185-91. PubMed ID: 15911734
    [Abstract] [Full Text] [Related]

  • 5. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).
    Cooper HA, Bloomfield DA, Bush DE, Katcher MS, Rawlins M, Sacco JD, Chandler M, AFFIRM Investigators.
    Am J Cardiol; 2004 May 15; 93(10):1247-53. PubMed ID: 15135698
    [Abstract] [Full Text] [Related]

  • 6. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, AFFIRM Investigators.
    Am Heart J; 2005 Apr 15; 149(4):645-9. PubMed ID: 15990747
    [Abstract] [Full Text] [Related]

  • 7. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
    Curtis AB, Seals AA, Safford RE, Slater W, Tullo NG, Vidaillet H, Wilber DJ, Slee A.
    Am Heart J; 2005 Feb 15; 149(2):304-8. PubMed ID: 15846269
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL, Safford RE, AFFIRM trial, RACE trial.
    Card Electrophysiol Rev; 2003 Dec 15; 7(4):366-9. PubMed ID: 15071255
    [Abstract] [Full Text] [Related]

  • 12. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG.
    Heart; 2009 Jun 15; 95(11):924-30. PubMed ID: 19282313
    [Abstract] [Full Text] [Related]

  • 13. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators.
    Am Heart J; 2005 Apr 15; 149(4):650-6. PubMed ID: 15990748
    [Abstract] [Full Text] [Related]

  • 14. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis.
    Kaufman ES, Zimmermann PA, Wang T, Dennish GW, Barrell PD, Chandler ML, Greene HL, Atrial Fibrillation Follow-up Investigation of Rhythm Management investigators.
    J Am Coll Cardiol; 2004 Sep 15; 44(6):1276-82. PubMed ID: 15364332
    [Abstract] [Full Text] [Related]

  • 15. Relation of initial resting ventricular rate to the ability to achieve and maintain normal sinus rhythm in patients with atrial fibrillation.
    Cooper HA, Sacco J, Solomon AJ, Feld GK, Leman R, Wilber D, AFFIRM Investigators.
    Am J Cardiol; 2005 Mar 01; 95(5):597-602. PubMed ID: 15721098
    [Abstract] [Full Text] [Related]

  • 16. Rate control versus rhythm control.
    Vidaillet H, Greenlee RT.
    Curr Opin Cardiol; 2005 Jan 01; 20(1):15-20. PubMed ID: 15596954
    [Abstract] [Full Text] [Related]

  • 17. Cognitive disorders in elderly patients with permanent atrial fibrillation.
    Wozakowska-Kapłon B, Opolski G, Kosior D, Jaskulska-Niedziela E, Maroszyńska-Dmoch E, Włosowicz M.
    Kardiol Pol; 2009 May 01; 67(5):487-93. PubMed ID: 19521933
    [Abstract] [Full Text] [Related]

  • 18. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, AFFIRM Investigators.
    Am Heart J; 2005 Apr 01; 149(4):657-63. PubMed ID: 15990749
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2340-7. PubMed ID: 17161267
    [Abstract] [Full Text] [Related]

  • 20. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
    Roy D, Rowe BH, Stiell IG, Coutu B, Ip JH, Phaneuf D, Lee J, Vidaillet H, Dickinson G, Grant S, Ezrin AM, Beatch GN, CRAFT Investigators.
    J Am Coll Cardiol; 2004 Dec 21; 44(12):2355-61. PubMed ID: 15607398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.